55 results
424B8
NMRD
Nemaura Medical Inc
11 Sep 23
Prospectus unintentially filed late
4:41pm
. This regulation places significant responsibility on the sponsor of the clinical study including, but not limited to, choosing qualified investigators
PRE 14A
NMRD
Nemaura Medical Inc
10 Aug 23
Preliminary proxy
4:05pm
with management and one another directly. Under these circumstances, the directors believe designating a lead director to take on responsibility for functions … responsibility in their respective areas of expertise.
The Audit Committee assists the Board with the oversight of our financial reporting, independent
POS AM
qcrd7jnwhnwpshqbzhud
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
424B4
uq5t3pp
15 May 23
Prospectus supplement with pricing info
4:31pm
CORRESP
w5shp8ihch3l47w3x6
11 May 23
Correspondence with SEC
12:00am
424B5
y8qes g4c6jetkhqn
1 Apr 22
Prospectus supplement for primary offering
4:29pm
CORRESP
41s6hc
24 Mar 22
Correspondence with SEC
12:00am
424B5
y1xg a003ailxyz
23 Jul 21
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
gudl87gmge
23 Jul 21
Entry into a Material Definitive Agreement
4:22pm